The majority of cancer patients today are diagnosed and treated outside the context of clinical research—that is, in the real world.
To improve the efficiency, efficacy, and cost of clinical trials, pharmaceutical companies are using real-world data at each stage of the drug development process.
From biomarker discovery and validation to trial design and label expansion, QIAGEN Real-World Insights (RWI) provides pharmaceutical development services to help you bridge the gap between actionable insight and real-world action.